Table 1.
Case | Gender |
Age
(year) |
Age at the onset of the first seizure (year) | Seizure frequency | Drug history | Histology and imaging | Seizures |
---|---|---|---|---|---|---|---|
1 | Female | 24 | 1 | 5-10 weekly | LEV, LTG | Sclerosis | GS |
2 | Male | 35 | 32 | 1-2 monthly | CBZ, VPA | Sclerosis | GS |
3 | Female | 39 | 4 | 2-3 monthly | LEV, CBZ, LTG | Sclerosis | GS |
4 | Female | 37 | 7 | 2-3 daily | CBZ, LTG, PRM | Sclerosis | GS |
5 | Female | 30 | 18 | 1-2 weekly | LEV, TOP | Sclerosis | GS |
6 | Male | 42 | 19 | 1 weekly | LEV, OCBZ | Sclerosis | GS |
7 | Male | 13 | 2 | 7-8 daily | VPA, OCBZ, LEV | Sclerosis + occipital lobe vascular abnormality | PS |
8 | Male | 30 | 5 | 3-4 monthly | LEV,VPA, CBZ, TOP | Sclerosis | PS |
CBZ: carbamazepine; GS: generalized seizures; LEV: levetiracetam; LTG: lamotrigin; OCBZ: oxcarbazepine; PS: partial seizure; TOP: Topiramate; VPA: valproate